Primary systemic vasculitis

Joanna Maj; Adam Reich; Eugeniusz Baran

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

5/2004
vol. 21

Send email

Copy url:

abstract:

Primary systemic vasculitis

Joanna Maj

,

Adam Reich

,

Eugeniusz Baran

PDiA 2004; XXI, 5: 247–254

Online publish date: 2004/10/27

View full text Get citation

The term primary systemic vasculitis describes a wide spectrum of systemic diseases of unknown etiology with different morphology, pathogenesis and clinical manifestations, but with one common feature, that is, the damage of vessels. Following diseases are considered as primary systemic vasculitis: cutaneous leukocytoclastic angiitis, Henoch-Schönlein purpura, cryoglobulinemic vasculitis, microscopic vasculitis, Wegener’s granulomatosis, Churg-Strauss syndrome, Kawasaki disease, polyarteritis nodosa, giant-cell arteritis and Takayasu disease. The most important factor responsible for the vessel damage is the deposition of antigen-antibody complexes within the vessel walls. The deposits activate complement and neutrophils, which impair blood vessels. The most often used treatment modalities consist of sulphones, colchicine, corticosteroids, cyclosporine, cyclophosphamide and azathioprine, and recently also new drugs, like etanercept, infliximab or rituximab are even employed.

keywords:

Primary systemic vasculitis

Joanna Maj , Adam Reich , Eugeniusz Baran

primary systemic vasculitis, diagnostics, therapy

Joanna Maj

,

Adam Reich

,

Eugeniusz Baran